P53 and PTEN Expression Contribute to the Inhibition of EGFR Downstream Signaling Pathway by Cetuximab

Cancer Gene Therapy - United Kingdom
doi 10.1038/cgt.2008.100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibition of the Ras-Erk Pathway in Mitotic COS7 Cells Is Due to the Inability of EGFR/Raf to Transduce EGF Signaling to Downstream Proteins

Oncology Reports
MedicineCancer ResearchOncology
2016English

Involvement of Parp1 in the Downstream of P53 Dependent Signaling Pathway Induced After Gamma-Irradiation

Journal of Translational Science
2018English

The Phosphatase Inhibitor Menadione (Vitamin K3) Protects Cells From EGFR Inhibition by Erlotinib and Cetuximab

Clinical Cancer Research
Cancer ResearchOncology
2011English

Inhibition of RIG-I-Dependent Signaling to the Interferon Pathway During Hepatitis C Virus Expression and Restoration of Signaling by IKK

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2005English

Contact-Dependent Inhibition of EGFR Signaling by Nf2/Merlin

Journal of Cell Biology
MedicineCell Biology
2007English

Dual Kinase Inhibition of EGFR and HER2 Overcomes Resistance to Cetuximab in a Novel in Vivo Model of Acquired Cetuximab Resistance

Clinical Cancer Research
Cancer ResearchOncology
2011English

Pressure Suppresses Hepatocellular Glycogen Synthesis Through Activating the P53/Pten Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Inhibition of EGFR Signaling Protects From Mucormycosis

mBio
VirologyMicrobiology
2018English

PTEN Loss Predicts Response to Notch Pathway Inhibition in Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy